Human trials on peptides like Selank remain small, short in duration, and largely conducted outside the U.S., which limits how confidently the results generalize
Explore our full range of ancillary research products
Larazotide is currently being studied for illnesses of intestinal permeability and is the subject of a late-phase clinical trial for patients with celiac disease, whose intestinal barrier is compromised
Peptide Therapy Compare the top 6 oral peptides including BPC-157, Rybelsus, and Selank
In COPD studies, GHK-Cu at 10 nanomolar concentration restored lung fibroblasts ability to contract and restructure collagen, a function that is severely compromised in COPD patients
BOC Sciences is a trusted global partner serving the life sciences, biotech, and pharmaceutical industries